| Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes WN Voss, YJ Hou, NV Johnson, G Delidakis, JE Kim, K Javanmardi, ... Science 372 (6546), 1108-1112, 2021 | 269 | 2021 |
| Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization E Salazar, SV Kuchipudi, PA Christensen, T Eagar, X Yi, P Zhao, Z Jin, ... The Journal of clinical investigation 130 (12), 6728-6738, 2020 | 181 | 2020 |
| Relationship between anti-spike protein antibody titers and SARS-CoV-2 in vitro virus neutralization in convalescent plasma E Salazar, SV Kuchipudi, PA Christensen, TN Eagar, X Yi, P Zhao, Z Jin, ... biorxiv, 2020 | 73 | 2020 |
| Graphene field effect biosensor for concurrent and specific detection of SARS-CoV-2 and influenza N Kumar, D Towers, S Myers, C Galvin, D Kireev, AD Ellington, ... ACS nano 17 (18), 18629-18640, 2023 | 14 | 2023 |
| Innovations and trends in antibody repertoire analysis DR Townsend, DM Towers, JJ Lavinder, GC Ippolito Current Opinion in Biotechnology 86, 103082, 2024 | 6 | 2024 |
| Comparison of media and standards for SARS-CoV-2 RT-qPCR without prior RNA preparation KB Ragan, S Bhadra, JH Choi, D Towers, CS Sullivan, AD Ellington medRxiv, 2020 | 2 | 2020 |
| Molecular features of the serological IgG repertoire elicited by egg-based, cell-based, or recombinant haemagglutinin-based seasonal influenza vaccines: a comparative … J Park, F Bartzoka, T von Beck, ZN Li, M Mishina, LS Hebert, J Kain, F Liu, ... The Lancet Microbe 6 (2), 2025 | 1 | 2025 |
| Multi-targeted, modular virus sensing platform D Akinwande, D Kireev, N Kumar, D Towers US Patent App. 18/714,512, 2025 | | 2025 |
